Biomarkers for the Assessment of Stroke/Systemic Embolism and Bleeding Risk in Patients With Atrial Fibrillation: A Nested Observational Study From ENGAGE AF-TIMI 48

被引：0
|
作者：
Berg, David D. [1 ]
Ruff, Christian T. [1 ]
Jarolim, Petr [2 ]
Giugliano, Robert P. [1 ]
Nordio, Francesco [1 ]
Lanz, Hans J. [3 ]
Mercuri, Michele [4 ]
Grosso, Michael [5 ]
Antman, Elliott M. [1 ]
Braunwald, Eugene [1 ]
Morrow, David A. [1 ]
机构：
[1] Brigham & Womens Hosp, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Pathol, 75 Francis St, Boston, MA 02115 USA
[3] Dauchi Sankyo, Global Med Affairs, Munich, Germany
[4] Daiichi Sankyo, Pharma Dev, Basking Ridge, NJ USA
[5] Daiichi Sankyo, Cardiovasc Clin Dev, Basking Ridge, NJ USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Atrial fibrillation; Biomarkers; Stroke; Anticoagulation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14367
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation Without Heart Failure in the ENGAGE AF-TIMI 48 Trial
    Eisen, Alon
    Ruff, Christian T.
    Braunwald, Eugene
    Hamershock, Rose A.
    Lewis, Basil S.
    Hassager, Christian
    LeHeuzey, Jean Yves
    Mercuri, Michele
    Rutman, Howard
    Antman, Elliott M.
    Giugliano, Robert P.
    CIRCULATION, 2016, 134
  • [42] Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial
    Douketis, James D.
    Murphy, Sabina A.
    Antman, Elliott M.
    Grip, Laura T.
    Mercuri, Michele F.
    Ruff, Christian T.
    Weitz, Jeffrey I.
    Braunwald, Eugene
    Giugliano, Robert P.
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (06) : 1001 - 1008
  • [43] Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial
    Park, Sungha
    Bergmark, Brian A.
    Shi, Minggao
    Lanz, Hans-Joachim
    Chung, Namsik
    Ruff, Christian T.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    HYPERTENSION, 2019, 74 (03) : 597 - 605
  • [44] Switching Patients From Blinded Study Drug to Warfarin at the End of the ENGAGE AF-TIMI 48 Trial Setting a New Standard
    Eikelboom, John W.
    Vanassche, Thomas
    Connolly, Stuart J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (06) : 585 - 587
  • [45] Renal Function and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation An Observational Cohort Study
    Bonde, Anders Nissen
    Lip, Gregory Y. H.
    Kamper, Anne-Lise
    Fosbol, Emil L.
    Staerk, Laila
    Carlson, Nicholas
    Torp-Pedersen, Christian
    Gislason, Gunnar
    Olesen, Jonas Bjerring
    STROKE, 2016, 47 (11) : 2707 - 2713
  • [46] Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
    Zimerman, Andre
    Braunwald, Eugene
    Steffel, Jan
    Van Mieghem, Nicolas M.
    Palazzolo, Michael G.
    Murphy, Sabina A.
    Chen, Cathy Zi Li
    Unverdorben, Martin
    Ruff, Christian T.
    Antman, Elliott M.
    Giugliano, Robert P.
    JAMA CARDIOLOGY, 2024, 9 (09) : 817 - 825
  • [47] Left Atrial Enlargement is an Independent Risk Factor of Stroke or Systemic Embolism in Atrial Fibrillation Patients: The Fushimi AF Registry
    Hamatani, Yasuhiro
    Takagi, Daisuke
    Ogawa, Hisashi
    Esato, Masahiro
    Chun, Yeong-Hwa
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Akao, Masaharu
    CIRCULATION, 2015, 132
  • [48] Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48
    Bonaca, Marc P.
    Antman, Elliott M.
    Cunningham, Jonathan W.
    Wiviott, Stephen D.
    Murphy, Sabina A.
    Halperin, Jonathan L.
    Weitz, Jeffrey, I
    Grosso, Michael A.
    Lanz, Hans J.
    Braunwald, Eugene
    Giugliano, Robert P.
    Ruff, Christian T.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (07) : 695 - 706
  • [49] Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
    Zelniker, Thomas A.
    Ardissino, Maddalena
    Andreotti, Felicita
    O'Donoghue, Michelle L.
    Yin, Ophelia
    Park, Jeong-Gun
    Murphy, Sabina A.
    Ruff, Christian T.
    Lanz, Hans J.
    Antman, Elliott M.
    Braunwald, Eugene
    Giugliano, Robert P.
    Merlini, Piera Angelica
    CIRCULATION, 2021, 143 (07) : 673 - 684
  • [50] Incidence and Risk Factors of Stroke or Systemic Embolism in Patients With Atrial Fibrillation and Heart Failure - The Fushimi AF Registry
    Iguchi, Moritake
    Tezuka, Yuji
    Ogawa, Hisashi
    Hamatani, Yasuhiro
    Takagi, Daisuke
    An, Yoshimori
    Unoki, Takashi
    Ishii, Mitsuru
    Masunaga, Nobutoyo
    Esato, Masahiro
    Tsuji, Hikari
    Wada, Hiromichi
    Hasegawa, Koji
    Abe, Mitsuru
    Lip, Gregory Y. H.
    Akao, Masaharu
    CIRCULATION JOURNAL, 2018, 82 (05) : 1327 - +
12345